Arogya Sanjeevani Policy of ManipalCigna Health Insurance, also Covers Coronavirus Treatment

▴ Arogya Sanjeevani Policy of ManipalCigna Health Insurance, also Covers Coronavirus Treatment
Arogya Sanjeevani Policy, ManipalCigna provides affordable all India health coverage also includes cover for modern treatments & procedures; hospitalisation coverage for infectious diseases like Coronavirus (Covid-19)

ManipalCigna Health Insurance Company Limited, a joint venture between Manipal Group, an eminent player in the field of healthcare delivery and higher education, U.S. based global health service leader, Cigna Corporation and Indian conglomerate TTK Group, recently announced the launch of its 'Arogya Sanjeevani Policy, ManipalCigna' in line with IRDAI's issued guidelines for a standard health cover policy. The product is specially designed to ensure that quality healthcare remains accessible and affordable to millions of people in India, especially in times when medical expenses are getting beyond everyone's reach.

'Arogya Sanjeevani Policy, ManipalCigna' is a simplified product that provides an essential health cover of Rs 1 lakh to Rs 5 lakhs for medical treatment of illnesses and injuries requiring in-patient hospitalization including for infectious diseases like Coronavirus (Covid-19) or similar such diseases and also provides cover for listed modern treatments & procedures. In addition, the product offers pre- hospitalization, post-hospitalization, AYUSH treatment, all day-care treatments, road ambulance, cumulative bonus in case of no claim and medical expenses if the insured undergoes a cataract surgery. The product also provides a family discount of 15% for covering 2 and more family members under the single individual policy to make it more affordable for families. There is an additional Online Renewal Discount of 3% p.a. from first renewal onwards, if the premium is received through NACH or Standing Instruction (where payment is made either by direct debit of bank account or credit card).

Speaking about the product launch, Prasun Sikdar, Managing Director and CEO, ManipalCigna Health Insurance Company Limited said, "Considering the growing medical inflation, and the rising infectious diseases like Coronavirus (Covid-19), having a health insurance coverage is a necessity for every individual and family. It's important for us to be prepared in advance and a safety net of health insurance coverage for yourself and family gives us protection against the medical expenses of the future. Our Arogya Sanjeevani, ManipalCigna Policy, could be a good choice for the first-time health insurance buyers in India as the policy is designed to provide access to quality health care while safeguarding your financial well-being."

Hospitalisation is a testing time for all and looking at the soaring healthcare costs, the product covers necessary hospitalization expenses incurred at any medical facility registered with ManipalCigna's network in India and even in non-network hospitals. It also covers the expenses incurred towards - dental treatment or plastic surgery necessitated due to disease or injury. Additionally, the policyholder will be provided a grace period of up to 30 days, for a yearly mode of payment. In case of a free-look period - the insured shall be allowed a period of fifteen days from date of receipt of the policy to review the terms and conditions of the policy, and to return the same if not acceptable.

Tags : #manipalcignahealthinsurance #covid-19treatment #arogyasanjeevanipolicy #moderntreatment

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024